Log In
Print this Print this

rostafuroxin (PST 2238)

  Manage Alerts
Collapse Summary General Information
Company Sigma-Tau Group
DescriptionDigitoxygenin derivative
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
PartnerCVie Therapeutics Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today